- Home
- VANI vs OKYO Comparison
VANI vs OKYO Comparison
Compare VANI & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- OKYO
- Stock Information
- Founded
- VANI 1998
- OKYO 2007
- Country
- VANI United States
- OKYO United Kingdom
- Employees
- VANI N/A
- OKYO N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VANI Health Care
- OKYO Health Care
- Exchange
- VANI Nasdaq
- OKYO Nasdaq
- Market Cap
- VANI 75.8M
- OKYO 85.0M
- IPO Year
- VANI 2014
- OKYO 2022
- Fundamental
- Price
- VANI $1.47
- OKYO $2.07
- Analyst Decision
- VANI Strong Buy
- OKYO Strong Buy
- Analyst Count
- VANI 1
- OKYO 1
- Target Price
- VANI $4.00
- OKYO $7.00
- AVG Volume (30 Days)
- VANI 140.9K
- OKYO 54.6K
- Earning Date
- VANI 11-12-2025
- OKYO 07-18-2025
- Dividend Yield
- VANI N/A
- OKYO N/A
- EPS Growth
- VANI N/A
- OKYO N/A
- EPS
- VANI N/A
- OKYO N/A
- Revenue
- VANI N/A
- OKYO N/A
- Revenue This Year
- VANI N/A
- OKYO N/A
- Revenue Next Year
- VANI N/A
- OKYO N/A
- P/E Ratio
- VANI N/A
- OKYO N/A
- Revenue Growth
- VANI N/A
- OKYO N/A
- 52 Week Low
- VANI $0.91
- OKYO $0.90
- 52 Week High
- VANI $1.80
- OKYO $3.35
- Technical
- Relative Strength Index (RSI)
- VANI 63.68
- OKYO 33.36
- Support Level
- VANI $1.19
- OKYO $2.06
- Resistance Level
- VANI $1.55
- OKYO $2.17
- Average True Range (ATR)
- VANI 0.10
- OKYO 0.14
- MACD
- VANI 0.03
- OKYO -0.00
- Stochastic Oscillator
- VANI 80.49
- OKYO 2.50
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.